We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+2.04%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$4.42B
AUM Growth
+$200M
Cap. Flow
+$138M
Cap. Flow %
3.13%
Top 10 Hldgs %
20.05%
Holding
1,701
New
123
Increased
762
Reduced
644
Closed
96

Sector Composition

Rank Sector Weight
1 Financials 4.64%
2 Technology 4.52%
3 Healthcare 4.42%
4 Consumer Staples 4.24%
5 Industrials 3.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRCM
1676
DELISTED
BROADCOM CORP CL-A
BRCM
-10,658
Closed -$616K
RBY
1677
DELISTED
RUBICON MENERALS CORP (F)
RBY
-12,047
Closed -$1K
SD
1678
DELISTED
SANDRIDGE ENERGY, INC.
SD
-30,010
Closed -$6K
TW
1679
DELISTED
TOWERS WATSON & CO COM STK CL A (DE)
TW
-2,726
Closed -$350K
ASBI
1680
DELISTED
AMERIANA BANCORP
ASBI
-69,500
Closed -$1.59M
RAS
1681
DELISTED
RAIT Financial Trust
RAS
-90,718
Closed -$245K
IRC
1682
DELISTED
INLAND REAL ESTATE CORP
IRC
-23,049
Closed -$245K
DZK
1683
DELISTED
Direxion Daily Developed Markets Bull 3x Shares
DZK
-4,029
Closed -$201K
PHF
1684
DELISTED
Pacholder High Yield
PHF
-11,584
Closed -$70K
HAWK
1685
DELISTED
Blackhawk Network Holdings, Inc. Common Stock
HAWK
-4,646
Closed -$205K
CB
1686
DELISTED
CHUBB CORPORATION
CB
-7,460
Closed -$989K
ALFA
1687
DELISTED
AlphaClone Alternative Alpha ETF
ALFA
-5,355
Closed -$201K
ETRM
1688
DELISTED
EnteroMedics Inc.
ETRM
-15
Closed -$2K
POM
1689
DELISTED
PEPCO HOLDINGS, INC.
POM
-21,324
Closed -$555K

Similar funds

Cambridge Investment Research Advisors's Q1 2016 Portfolio in Review

As of Q1 2016, Cambridge Investment Research Advisors held 1,701 positions worth $4.42B, up 4.7% from $4.22B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Cambridge Investment Research Advisors deployed $138M of net new capital in Q1 2016, opening 123 new positions and adding to 762 existing holdings. Its largest new stake was Vanguard Long-Term Treasury ETF: 35,170 shares worth $2.83M.

By sector, the portfolio is most concentrated in Financials at 4.6% of assets, down from 4.9% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $20.4M trimmed.

  • Cambridge Investment Research Advisors's largest Q1 2016 buy was Vanguard Long-Term Treasury ETF: 35,170 shares worth $2.83M.
  • Cambridge Investment Research Advisors added most to DIPLOMAT PHARMACY, INC. in Q1 2016, an estimated $34.6M increase.
  • Cambridge Investment Research Advisors's biggest Q1 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $20.4M.
  • Cambridge Investment Research Advisors fully exited iShares Currency Hedged MSCI Emerging Markets in Q1 2016, selling an estimated $1.72M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 20% of its $4.42B portfolio in Q1 2016.
  • Cambridge Investment Research Advisors opened 123 new positions and closed 96 in Q1 2016.
  • Cambridge Investment Research Advisors's portfolio value rose 4.7% quarter-over-quarter to $4.42B.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2016, filed 3 May 2016.